FindTrial
Sign In

Efficacy and safety of different molecular weight sodium hyaluronate in patients with knee osteoarthritis: a prospective, multicenter, double-blind, randomized controlled trial

Efficacy and safety of different molecular weight sodium hyaluronate in patients with knee osteoarthritis: a prospective, multicenter, double-blind, randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015812
Enrollment
Unknown
Registered
2018-04-22
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

A:Large molecular weight sodium hyaluronate
B:middle molecular weight sodium hyaluronate
C:small molecular weight sodium hyaluronate
D:placebo

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: KOA patientsk-l2-3

Exclusion criteria

Exclusion criteria: infection and operatian in a short period k-l:4

Design outcomes

Primary

MeasureTime frame
Function measure;IF-6 ESR CRP;X ray, MRI;—

Countries

China

Contacts

Public ContactZongke Zhou

West China Hospital, Sichuan University

zongke@126.com+86 18980601028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026